Ubrelvy (ubrogepant) and Nurtec (rimegepant) are prescription medications approved to help manage and offer relief for people dealing with migraine headaches with or without aura. Both belong to a ...

They can help you decide if one of these medications is right for you. Ubrelvy, Nurtec ODT, and Imitrex are all used to treat migraine episodes that occur with or without aura. Ubrelvy and Nurtec ...

The latter isn't going to happen of course. AbbVie recorded sales of more than $1.2 billion for Ubrelvy and partner migraine drug Qulipta for episodic and chronic migraine prevention last year.

Nurtec ODT is a prescription drug that’s prescribed for migraine. The drug comes as a tablet that you dissolve on or under your tongue. How often you take Nurtec ODT depends on whether you’re ...

AbbVie sells another oral CGRP called Ubrelvy (ubrogepant) for acute treatment of migraine, which made around $552 million last year, and hasn't yet disclosed Qulipta's quarterly sales performance.

For children and teens living with migraine, there may be a new preventive treatment, according to a preliminary study released today, February 26, 2025, that will be presented at the American Academy ...